1 Schuster M, Engelhardt L, Erler W, et al. Levobupivacaine vs. pivacaine for continuous femoral anal gesia after anterior cruciate ligament reconstruction[J]. Schmerz, 2011, 25(1): 62-68.
[2]
2 Higgins LD, Taylor MK, Park DA, et al. Reliability and validity of the International Knee Documentation Committee (IKDC) Subjective Knee Form[J]. Joint Bone Spine, 2007, 74(6): 594-599.
[3]
3 Noonan B, Chung KS. A practical review of the mechanisms of pain and pain management following ACL reconstruction[J]. Orthopedics, 2006, 29(11): 999-1005.
[4]
4 Wulf H, Loewe J, Gnutzmann KH, et al. Femoral nerve block with ropivacaine or bupivacaine in day case anterior crucial ligament reconstruction[J]. Acta Anaesthesiol Scand, 2010, 54(4): 414-420.
[5]
5 Viscusi ER, Parvizi J, Tarity TD. Developments in spinal and epidural anesthesia and nerve blocks for total joint arthroplasty: what is new and exciting in pain management[J]. Instr Course Lect, 2007, 56: 139-145.
[6]
6 Coda BA, Hill HF, Hunt EB, et al. Cognitive and motor function impairments during continuous opioid analgesic infusions[J]. Hum Psychopharmacol, 1993, 8(8): 383-400.
[7]
7 Kimmel SE, Berlin JA, Reilly M, et al. Patients exposed to rofecoxib and celecoxib have different odds of nonfatal myocardial infarction[J]. Ann Intern Med, 2005, 142(3): 157-164.
[8]
8 Brophy JM. Celecoxib and cardiovascular risks[J]. Expert Opin Drag Saf, 2005, 4(6): 1005-1015．
[9]
9 Tali M, Maaroos J. Lower limbs function and pain relationships after unilateral total knee arthroplasty[J]. Int J Rehabil Res, 2010, 33(3): 264-267.
[10]
10 Wheeler M, Oderda GM, Ashburn MA, et al. Adverse events associated with postoperative opioid analgesia: a systematic review[J]. J Pain, 2002, 3(3): 159-180.
[11]
11 Brokelman RB, Van Loon CJ, Rijnberg WJ. Patient versus surgeon satisfaction after total hip arthroplasty[J]. J Bone Joint Surg Br, 2003, 85(4): 495-498.
